nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—CYP3A4—Everolimus—kidney cancer	0.132	0.215	CbGbCtD
MACITENTAN—ALB—Erlotinib—kidney cancer	0.106	0.174	CbGbCtD
MACITENTAN—CYP3A4—Temsirolimus—kidney cancer	0.0889	0.145	CbGbCtD
MACITENTAN—CYP2C19—Sorafenib—kidney cancer	0.056	0.0916	CbGbCtD
MACITENTAN—CYP3A4—Pazopanib—kidney cancer	0.0467	0.0763	CbGbCtD
MACITENTAN—CYP3A4—Erlotinib—kidney cancer	0.0333	0.0545	CbGbCtD
MACITENTAN—CYP3A4—Paclitaxel—kidney cancer	0.0305	0.0498	CbGbCtD
MACITENTAN—CYP3A4—Sorafenib—kidney cancer	0.0271	0.0443	CbGbCtD
MACITENTAN—CYP3A4—Vinblastine—kidney cancer	0.0268	0.0437	CbGbCtD
MACITENTAN—CYP3A4—Vincristine—kidney cancer	0.0263	0.043	CbGbCtD
MACITENTAN—CYP3A4—Sunitinib—kidney cancer	0.0219	0.0359	CbGbCtD
MACITENTAN—CYP3A4—Doxorubicin—kidney cancer	0.0164	0.0269	CbGbCtD
MACITENTAN—Hepatotoxicity—Pazopanib—kidney cancer	0.00717	0.0302	CcSEcCtD
MACITENTAN—Fluid retention—Temsirolimus—kidney cancer	0.00558	0.0235	CcSEcCtD
MACITENTAN—Hepatotoxicity—Erlotinib—kidney cancer	0.00546	0.023	CcSEcCtD
MACITENTAN—Hepatotoxicity—Sunitinib—kidney cancer	0.00473	0.0199	CcSEcCtD
MACITENTAN—Hepatotoxicity—Dactinomycin—kidney cancer	0.00447	0.0189	CcSEcCtD
MACITENTAN—Fluid retention—Everolimus—kidney cancer	0.00415	0.0175	CcSEcCtD
MACITENTAN—Hepatotoxicity—Gemcitabine—kidney cancer	0.00379	0.016	CcSEcCtD
MACITENTAN—Influenza—Temsirolimus—kidney cancer	0.00369	0.0155	CcSEcCtD
MACITENTAN—Nasopharyngitis—Pazopanib—kidney cancer	0.00359	0.0151	CcSEcCtD
MACITENTAN—Bronchitis—Temsirolimus—kidney cancer	0.00354	0.0149	CcSEcCtD
MACITENTAN—Infestation—Temsirolimus—kidney cancer	0.00329	0.0138	CcSEcCtD
MACITENTAN—Infestation NOS—Temsirolimus—kidney cancer	0.00329	0.0138	CcSEcCtD
MACITENTAN—Urinary tract infection—Temsirolimus—kidney cancer	0.00319	0.0135	CcSEcCtD
MACITENTAN—CYP2C19—urine—kidney cancer	0.00313	0.238	CbGeAlD
MACITENTAN—Infestation—Pazopanib—kidney cancer	0.0031	0.013	CcSEcCtD
MACITENTAN—Infestation NOS—Pazopanib—kidney cancer	0.0031	0.013	CcSEcCtD
MACITENTAN—Pharyngitis—Temsirolimus—kidney cancer	0.00293	0.0123	CcSEcCtD
MACITENTAN—Nasopharyngitis—Everolimus—kidney cancer	0.00284	0.012	CcSEcCtD
MACITENTAN—Fluid retention—Gemcitabine—kidney cancer	0.00278	0.0117	CcSEcCtD
MACITENTAN—Influenza—Everolimus—kidney cancer	0.00274	0.0116	CcSEcCtD
MACITENTAN—Angiopathy—Temsirolimus—kidney cancer	0.00268	0.0113	CcSEcCtD
MACITENTAN—Bronchitis—Everolimus—kidney cancer	0.00264	0.0111	CcSEcCtD
MACITENTAN—Hepatotoxicity—Capecitabine—kidney cancer	0.00261	0.011	CcSEcCtD
MACITENTAN—Angiopathy—Pazopanib—kidney cancer	0.00252	0.0106	CcSEcCtD
MACITENTAN—Nasopharyngitis—Sorafenib—kidney cancer	0.00246	0.0104	CcSEcCtD
MACITENTAN—Infestation NOS—Everolimus—kidney cancer	0.00244	0.0103	CcSEcCtD
MACITENTAN—Infestation—Everolimus—kidney cancer	0.00244	0.0103	CcSEcCtD
MACITENTAN—Urinary tract infection—Everolimus—kidney cancer	0.00238	0.01	CcSEcCtD
MACITENTAN—Anaemia—Temsirolimus—kidney cancer	0.00237	0.01	CcSEcCtD
MACITENTAN—Nasopharyngitis—Sunitinib—kidney cancer	0.00237	0.00998	CcSEcCtD
MACITENTAN—Infestation NOS—Erlotinib—kidney cancer	0.00236	0.00994	CcSEcCtD
MACITENTAN—Infestation—Erlotinib—kidney cancer	0.00236	0.00994	CcSEcCtD
MACITENTAN—Fluid retention—Paclitaxel—kidney cancer	0.00233	0.00981	CcSEcCtD
MACITENTAN—Anaemia—Pazopanib—kidney cancer	0.00224	0.00942	CcSEcCtD
MACITENTAN—Bronchitis—Sunitinib—kidney cancer	0.0022	0.00928	CcSEcCtD
MACITENTAN—Pharyngitis—Vinblastine—kidney cancer	0.00219	0.00921	CcSEcCtD
MACITENTAN—Pharyngitis—Everolimus—kidney cancer	0.00218	0.00918	CcSEcCtD
MACITENTAN—Infestation NOS—Sorafenib—kidney cancer	0.00212	0.00894	CcSEcCtD
MACITENTAN—Infestation—Sorafenib—kidney cancer	0.00212	0.00894	CcSEcCtD
MACITENTAN—Oedema—Temsirolimus—kidney cancer	0.0021	0.00883	CcSEcCtD
MACITENTAN—Infection—Temsirolimus—kidney cancer	0.00208	0.00877	CcSEcCtD
MACITENTAN—Nervous system disorder—Temsirolimus—kidney cancer	0.00206	0.00866	CcSEcCtD
MACITENTAN—EDNRB—cortex of kidney—kidney cancer	0.00205	0.155	CbGeAlD
MACITENTAN—Infestation—Sunitinib—kidney cancer	0.00204	0.0086	CcSEcCtD
MACITENTAN—Infestation NOS—Sunitinib—kidney cancer	0.00204	0.0086	CcSEcCtD
MACITENTAN—Angiopathy—Everolimus—kidney cancer	0.00199	0.00839	CcSEcCtD
MACITENTAN—Urinary tract infection—Sunitinib—kidney cancer	0.00198	0.00836	CcSEcCtD
MACITENTAN—Oedema—Pazopanib—kidney cancer	0.00197	0.00832	CcSEcCtD
MACITENTAN—Infection—Pazopanib—kidney cancer	0.00196	0.00827	CcSEcCtD
MACITENTAN—EDNRB—cardiac atrium—kidney cancer	0.00195	0.148	CbGeAlD
MACITENTAN—Nervous system disorder—Pazopanib—kidney cancer	0.00194	0.00816	CcSEcCtD
MACITENTAN—Fluid retention—Capecitabine—kidney cancer	0.00191	0.00805	CcSEcCtD
MACITENTAN—CYP3A4—urine—kidney cancer	0.00185	0.141	CbGeAlD
MACITENTAN—Influenza—Gemcitabine—kidney cancer	0.00184	0.00774	CcSEcCtD
MACITENTAN—Anaemia—Vinblastine—kidney cancer	0.00177	0.00747	CcSEcCtD
MACITENTAN—Anaemia—Everolimus—kidney cancer	0.00177	0.00744	CcSEcCtD
MACITENTAN—Angiopathy—Sorafenib—kidney cancer	0.00173	0.00728	CcSEcCtD
MACITENTAN—Pharyngitis—Dactinomycin—kidney cancer	0.00172	0.00726	CcSEcCtD
MACITENTAN—EDNRA—cortex of kidney—kidney cancer	0.00169	0.128	CbGeAlD
MACITENTAN—Angiopathy—Sunitinib—kidney cancer	0.00166	0.00701	CcSEcCtD
MACITENTAN—EDNRA—cardiac atrium—kidney cancer	0.00161	0.122	CbGeAlD
MACITENTAN—Nasopharyngitis—Paclitaxel—kidney cancer	0.00159	0.00671	CcSEcCtD
MACITENTAN—Oedema—Everolimus—kidney cancer	0.00156	0.00657	CcSEcCtD
MACITENTAN—Infection—Everolimus—kidney cancer	0.00155	0.00653	CcSEcCtD
MACITENTAN—Influenza—Paclitaxel—kidney cancer	0.00154	0.00648	CcSEcCtD
MACITENTAN—Anaemia—Sorafenib—kidney cancer	0.00153	0.00646	CcSEcCtD
MACITENTAN—Nervous system disorder—Everolimus—kidney cancer	0.00153	0.00644	CcSEcCtD
MACITENTAN—Oedema—Erlotinib—kidney cancer	0.0015	0.00634	CcSEcCtD
MACITENTAN—Infection—Erlotinib—kidney cancer	0.00149	0.0063	CcSEcCtD
MACITENTAN—Bronchitis—Paclitaxel—kidney cancer	0.00148	0.00623	CcSEcCtD
MACITENTAN—Nervous system disorder—Erlotinib—kidney cancer	0.00148	0.00622	CcSEcCtD
MACITENTAN—Anaemia—Sunitinib—kidney cancer	0.00147	0.00621	CcSEcCtD
MACITENTAN—Pharyngitis—Gemcitabine—kidney cancer	0.00146	0.00615	CcSEcCtD
MACITENTAN—Hypotension—Everolimus—kidney cancer	0.00146	0.00614	CcSEcCtD
MACITENTAN—Angiopathy—Vincristine—kidney cancer	0.00141	0.00593	CcSEcCtD
MACITENTAN—Anaemia—Dactinomycin—kidney cancer	0.0014	0.00588	CcSEcCtD
MACITENTAN—Infestation NOS—Paclitaxel—kidney cancer	0.00137	0.00578	CcSEcCtD
MACITENTAN—Infestation—Paclitaxel—kidney cancer	0.00137	0.00578	CcSEcCtD
MACITENTAN—Infection—Sorafenib—kidney cancer	0.00134	0.00567	CcSEcCtD
MACITENTAN—Angiopathy—Gemcitabine—kidney cancer	0.00133	0.00562	CcSEcCtD
MACITENTAN—Urinary tract infection—Paclitaxel—kidney cancer	0.00133	0.00562	CcSEcCtD
MACITENTAN—Nervous system disorder—Sorafenib—kidney cancer	0.00133	0.00559	CcSEcCtD
MACITENTAN—Headache—Temsirolimus—kidney cancer	0.00131	0.00553	CcSEcCtD
MACITENTAN—Nasopharyngitis—Capecitabine—kidney cancer	0.00131	0.0055	CcSEcCtD
MACITENTAN—Oedema—Sunitinib—kidney cancer	0.0013	0.00549	CcSEcCtD
MACITENTAN—Infection—Sunitinib—kidney cancer	0.00129	0.00545	CcSEcCtD
MACITENTAN—Nervous system disorder—Sunitinib—kidney cancer	0.00128	0.00538	CcSEcCtD
MACITENTAN—Influenza—Capecitabine—kidney cancer	0.00126	0.00532	CcSEcCtD
MACITENTAN—Anaemia—Vincristine—kidney cancer	0.00125	0.00526	CcSEcCtD
MACITENTAN—Headache—Pazopanib—kidney cancer	0.00124	0.00521	CcSEcCtD
MACITENTAN—Oedema—Dactinomycin—kidney cancer	0.00123	0.00519	CcSEcCtD
MACITENTAN—Fluid retention—Doxorubicin—kidney cancer	0.00123	0.00519	CcSEcCtD
MACITENTAN—Infection—Dactinomycin—kidney cancer	0.00122	0.00516	CcSEcCtD
MACITENTAN—Pharyngitis—Paclitaxel—kidney cancer	0.00122	0.00515	CcSEcCtD
MACITENTAN—Bronchitis—Capecitabine—kidney cancer	0.00121	0.00512	CcSEcCtD
MACITENTAN—Anaemia—Gemcitabine—kidney cancer	0.00118	0.00499	CcSEcCtD
MACITENTAN—Infestation—Capecitabine—kidney cancer	0.00113	0.00474	CcSEcCtD
MACITENTAN—Infestation NOS—Capecitabine—kidney cancer	0.00113	0.00474	CcSEcCtD
MACITENTAN—Angiopathy—Paclitaxel—kidney cancer	0.00112	0.00471	CcSEcCtD
MACITENTAN—Oedema—Vincristine—kidney cancer	0.0011	0.00464	CcSEcCtD
MACITENTAN—Infection—Vincristine—kidney cancer	0.00109	0.00461	CcSEcCtD
MACITENTAN—Urinary tract infection—Capecitabine—kidney cancer	0.00109	0.00461	CcSEcCtD
MACITENTAN—Nervous system disorder—Vincristine—kidney cancer	0.00108	0.00455	CcSEcCtD
MACITENTAN—Oedema—Gemcitabine—kidney cancer	0.00104	0.0044	CcSEcCtD
MACITENTAN—Infection—Gemcitabine—kidney cancer	0.00104	0.00437	CcSEcCtD
MACITENTAN—Hypotension—Vincristine—kidney cancer	0.00103	0.00434	CcSEcCtD
MACITENTAN—Nervous system disorder—Gemcitabine—kidney cancer	0.00102	0.00432	CcSEcCtD
MACITENTAN—Pharyngitis—Capecitabine—kidney cancer	0.001	0.00423	CcSEcCtD
MACITENTAN—Anaemia—Paclitaxel—kidney cancer	0.000991	0.00417	CcSEcCtD
MACITENTAN—Headache—Vinblastine—kidney cancer	0.00098	0.00413	CcSEcCtD
MACITENTAN—Headache—Everolimus—kidney cancer	0.000977	0.00412	CcSEcCtD
MACITENTAN—Hypotension—Gemcitabine—kidney cancer	0.000976	0.00411	CcSEcCtD
MACITENTAN—Headache—Erlotinib—kidney cancer	0.000942	0.00397	CcSEcCtD
MACITENTAN—Angiopathy—Capecitabine—kidney cancer	0.000917	0.00386	CcSEcCtD
MACITENTAN—Oedema—Paclitaxel—kidney cancer	0.000875	0.00369	CcSEcCtD
MACITENTAN—Infection—Paclitaxel—kidney cancer	0.000869	0.00366	CcSEcCtD
MACITENTAN—Nervous system disorder—Paclitaxel—kidney cancer	0.000858	0.00362	CcSEcCtD
MACITENTAN—Headache—Sorafenib—kidney cancer	0.000848	0.00357	CcSEcCtD
MACITENTAN—Nasopharyngitis—Doxorubicin—kidney cancer	0.000842	0.00355	CcSEcCtD
MACITENTAN—Hypotension—Paclitaxel—kidney cancer	0.000817	0.00344	CcSEcCtD
MACITENTAN—Headache—Sunitinib—kidney cancer	0.000816	0.00344	CcSEcCtD
MACITENTAN—Influenza—Doxorubicin—kidney cancer	0.000814	0.00343	CcSEcCtD
MACITENTAN—Anaemia—Capecitabine—kidney cancer	0.000813	0.00343	CcSEcCtD
MACITENTAN—Bronchitis—Doxorubicin—kidney cancer	0.000783	0.0033	CcSEcCtD
MACITENTAN—Infestation NOS—Doxorubicin—kidney cancer	0.000726	0.00306	CcSEcCtD
MACITENTAN—Infestation—Doxorubicin—kidney cancer	0.000726	0.00306	CcSEcCtD
MACITENTAN—Oedema—Capecitabine—kidney cancer	0.000718	0.00303	CcSEcCtD
MACITENTAN—Infection—Capecitabine—kidney cancer	0.000713	0.00301	CcSEcCtD
MACITENTAN—Urinary tract infection—Doxorubicin—kidney cancer	0.000705	0.00297	CcSEcCtD
MACITENTAN—Nervous system disorder—Capecitabine—kidney cancer	0.000704	0.00297	CcSEcCtD
MACITENTAN—Headache—Vincristine—kidney cancer	0.00069	0.00291	CcSEcCtD
MACITENTAN—Hypotension—Capecitabine—kidney cancer	0.000671	0.00283	CcSEcCtD
MACITENTAN—Headache—Gemcitabine—kidney cancer	0.000655	0.00276	CcSEcCtD
MACITENTAN—Pharyngitis—Doxorubicin—kidney cancer	0.000646	0.00272	CcSEcCtD
MACITENTAN—Angiopathy—Doxorubicin—kidney cancer	0.000591	0.00249	CcSEcCtD
MACITENTAN—Headache—Paclitaxel—kidney cancer	0.000548	0.00231	CcSEcCtD
MACITENTAN—Anaemia—Doxorubicin—kidney cancer	0.000524	0.00221	CcSEcCtD
MACITENTAN—Oedema—Doxorubicin—kidney cancer	0.000463	0.00195	CcSEcCtD
MACITENTAN—Infection—Doxorubicin—kidney cancer	0.00046	0.00194	CcSEcCtD
MACITENTAN—Nervous system disorder—Doxorubicin—kidney cancer	0.000454	0.00191	CcSEcCtD
MACITENTAN—CYP3A4—renal system—kidney cancer	0.000453	0.0344	CbGeAlD
MACITENTAN—Headache—Capecitabine—kidney cancer	0.00045	0.0019	CcSEcCtD
MACITENTAN—CYP3A4—kidney—kidney cancer	0.000438	0.0333	CbGeAlD
MACITENTAN—Hypotension—Doxorubicin—kidney cancer	0.000432	0.00182	CcSEcCtD
MACITENTAN—Headache—Doxorubicin—kidney cancer	0.00029	0.00122	CcSEcCtD
MACITENTAN—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000123	0.000894	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000123	0.000894	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—POMC—kidney cancer	0.00012	0.000869	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTM1—kidney cancer	0.000118	0.000858	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KCNMA1—kidney cancer	0.000118	0.000856	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000117	0.000847	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	0.000117	0.000846	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000114	0.000828	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	0.000112	0.000813	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CTNNA1—kidney cancer	0.000112	0.000812	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTT1—kidney cancer	0.000112	0.00081	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EIF4EBP1—kidney cancer	0.000111	0.000807	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HSPB1—kidney cancer	0.000111	0.000807	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	0.00011	0.000802	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ACY1—kidney cancer	0.00011	0.000797	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VEGFA—kidney cancer	0.000108	0.000783	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF2—kidney cancer	0.000106	0.000769	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN2B—kidney cancer	0.000105	0.000766	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—PTGS1—kidney cancer	0.000105	0.000759	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PSMD7—kidney cancer	0.000103	0.00075	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TSC1—kidney cancer	0.000103	0.00075	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ANXA1—kidney cancer	0.000103	0.00075	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—GRB7—kidney cancer	0.000103	0.000747	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.000103	0.000746	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF1R—kidney cancer	0.000102	0.000744	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FLT1—kidney cancer	0.0001	0.000727	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—RAF1—kidney cancer	9.87e-05	0.000717	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ACY1—kidney cancer	9.85e-05	0.000716	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2—kidney cancer	9.75e-05	0.000708	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ITPR2—kidney cancer	9.56e-05	0.000694	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—kidney cancer	9.5e-05	0.00069	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.46e-05	0.000687	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—POMC—kidney cancer	9.44e-05	0.000685	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	9.36e-05	0.00068	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PDHB—kidney cancer	9.33e-05	0.000678	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—JUNB—kidney cancer	9.28e-05	0.000674	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PAK1—kidney cancer	9.28e-05	0.000674	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL2—kidney cancer	8.85e-05	0.000643	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CCBL1—kidney cancer	8.78e-05	0.000637	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—POMC—kidney cancer	8.57e-05	0.000622	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HIF1A—kidney cancer	8.43e-05	0.000612	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TSC2—kidney cancer	8.41e-05	0.000611	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.4e-05	0.00061	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PDHB—kidney cancer	8.38e-05	0.000608	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—POMC—kidney cancer	8.35e-05	0.000607	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KDR—kidney cancer	8.07e-05	0.000586	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.94e-05	0.000576	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CCBL1—kidney cancer	7.88e-05	0.000572	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTP1—kidney cancer	7.73e-05	0.000562	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	7.63e-05	0.000554	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GLIPR1—kidney cancer	7.61e-05	0.000553	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPAT—kidney cancer	7.61e-05	0.000553	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF2—kidney cancer	7.58e-05	0.000551	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN2B—kidney cancer	7.55e-05	0.000548	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.51e-05	0.000546	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.44e-05	0.00054	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—APC—kidney cancer	7.43e-05	0.00054	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KIT—kidney cancer	7.43e-05	0.00054	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF1R—kidney cancer	7.33e-05	0.000532	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.12e-05	0.000517	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK3—kidney cancer	7.12e-05	0.000517	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.11e-05	0.000516	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APRT—kidney cancer	7.07e-05	0.000514	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—FH—kidney cancer	7.07e-05	0.000514	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—POMC—kidney cancer	7.07e-05	0.000514	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—RAF1—kidney cancer	7.07e-05	0.000513	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IFNA1—kidney cancer	7.02e-05	0.000509	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.01e-05	0.000509	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BRAF—kidney cancer	6.98e-05	0.000507	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2—kidney cancer	6.98e-05	0.000507	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.91e-05	0.000502	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GLIPR1—kidney cancer	6.83e-05	0.000496	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPAT—kidney cancer	6.83e-05	0.000496	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK1—kidney cancer	6.77e-05	0.000492	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.74e-05	0.00049	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	6.74e-05	0.000489	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.68e-05	0.000485	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPC3—kidney cancer	6.65e-05	0.000483	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	6.64e-05	0.000482	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IFNA2—kidney cancer	6.53e-05	0.000474	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.49e-05	0.000472	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CA—kidney cancer	6.47e-05	0.00047	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CA2—kidney cancer	6.47e-05	0.00047	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—KRAS—kidney cancer	6.4e-05	0.000464	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—FH—kidney cancer	6.35e-05	0.000461	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APRT—kidney cancer	6.35e-05	0.000461	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—kidney cancer	6.33e-05	0.00046	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ALAD—kidney cancer	6.3e-05	0.000458	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	6.28e-05	0.000456	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.27e-05	0.000455	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.21e-05	0.000451	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ST3GAL2—kidney cancer	6.15e-05	0.000447	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HIF1A—kidney cancer	6.04e-05	0.000438	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TSC2—kidney cancer	6.02e-05	0.000437	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ALDH1A1—kidney cancer	6.01e-05	0.000437	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPC3—kidney cancer	5.97e-05	0.000434	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ACY1—kidney cancer	5.93e-05	0.00043	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF2—kidney cancer	5.88e-05	0.000427	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CA—kidney cancer	5.88e-05	0.000427	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RAF1—kidney cancer	5.83e-05	0.000423	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CA2—kidney cancer	5.81e-05	0.000422	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RELA—kidney cancer	5.81e-05	0.000422	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KDR—kidney cancer	5.77e-05	0.000419	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ERBB2—kidney cancer	5.77e-05	0.000419	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC5A3—kidney cancer	5.77e-05	0.000419	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PGK1—kidney cancer	5.77e-05	0.000419	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MTOR—kidney cancer	5.69e-05	0.000413	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALAD—kidney cancer	5.66e-05	0.000411	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LDHB—kidney cancer	5.65e-05	0.000411	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	5.63e-05	0.000409	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ST3GAL2—kidney cancer	5.52e-05	0.000401	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALDH1A1—kidney cancer	5.4e-05	0.000392	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN1B—kidney cancer	5.34e-05	0.000388	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KIT—kidney cancer	5.32e-05	0.000386	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—APC—kidney cancer	5.32e-05	0.000386	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—kidney cancer	5.23e-05	0.00038	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.18e-05	0.000376	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PGK1—kidney cancer	5.18e-05	0.000376	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCND1—kidney cancer	5.1e-05	0.00037	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK3—kidney cancer	5.09e-05	0.00037	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—JUN—kidney cancer	5.09e-05	0.000369	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LDHB—kidney cancer	5.08e-05	0.000369	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—POMC—kidney cancer	5.06e-05	0.000368	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CTNNB1—kidney cancer	5.05e-05	0.000367	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PDHB—kidney cancer	5.04e-05	0.000366	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—POMC—kidney cancer	5.02e-05	0.000365	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BRAF—kidney cancer	5e-05	0.000363	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.95e-05	0.00036	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTEN—kidney cancer	4.92e-05	0.000357	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CA9—kidney cancer	4.9e-05	0.000356	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK1—kidney cancer	4.85e-05	0.000352	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.79e-05	0.000348	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	4.78e-05	0.000347	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CCBL1—kidney cancer	4.74e-05	0.000344	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CA—kidney cancer	4.63e-05	0.000336	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—KRAS—kidney cancer	4.58e-05	0.000332	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	4.53e-05	0.000329	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—kidney cancer	4.44e-05	0.000323	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CA9—kidney cancer	4.4e-05	0.00032	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	4.31e-05	0.000313	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.3e-05	0.000312	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CA—kidney cancer	4.2e-05	0.000305	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK3—kidney cancer	4.2e-05	0.000305	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RAF1—kidney cancer	4.17e-05	0.000303	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CRABP1—kidney cancer	4.17e-05	0.000303	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RELA—kidney cancer	4.16e-05	0.000302	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ERBB2—kidney cancer	4.13e-05	0.0003	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.11e-05	0.000298	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPAT—kidney cancer	4.11e-05	0.000298	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MYC—kidney cancer	4.09e-05	0.000297	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MTOR—kidney cancer	4.07e-05	0.000296	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK1—kidney cancer	4e-05	0.00029	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ITPR2—kidney cancer	3.88e-05	0.000281	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN1B—kidney cancer	3.82e-05	0.000278	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—FH—kidney cancer	3.82e-05	0.000277	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APRT—kidney cancer	3.82e-05	0.000277	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KRAS—kidney cancer	3.78e-05	0.000274	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CRABP1—kidney cancer	3.74e-05	0.000272	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—kidney cancer	3.74e-05	0.000272	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.74e-05	0.000271	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCND1—kidney cancer	3.65e-05	0.000265	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—JUN—kidney cancer	3.64e-05	0.000264	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CTNNB1—kidney cancer	3.61e-05	0.000262	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPC3—kidney cancer	3.59e-05	0.000261	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.57e-05	0.000259	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTT1—kidney cancer	3.53e-05	0.000257	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ACHE—kidney cancer	3.53e-05	0.000257	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTEN—kidney cancer	3.52e-05	0.000256	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CA2—kidney cancer	3.49e-05	0.000254	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ITPR2—kidney cancer	3.48e-05	0.000253	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CA—kidney cancer	3.47e-05	0.000252	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALAD—kidney cancer	3.4e-05	0.000247	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—kidney cancer	3.36e-05	0.000244	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SCARB1—kidney cancer	3.35e-05	0.000243	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.32e-05	0.000241	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS1—kidney cancer	3.31e-05	0.00024	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PSMD7—kidney cancer	3.25e-05	0.000236	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.25e-05	0.000236	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAF1—kidney cancer	3.24e-05	0.000235	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.21e-05	0.000233	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—kidney cancer	3.18e-05	0.000231	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTT1—kidney cancer	3.17e-05	0.00023	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ACHE—kidney cancer	3.17e-05	0.00023	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PGK1—kidney cancer	3.11e-05	0.000226	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.11e-05	0.000226	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—BCHE—kidney cancer	3.08e-05	0.000224	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LDHB—kidney cancer	3.05e-05	0.000222	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC5A5—kidney cancer	3.04e-05	0.000221	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK3—kidney cancer	3.01e-05	0.000218	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SCARB1—kidney cancer	3e-05	0.000218	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS1—kidney cancer	2.97e-05	0.000216	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC2A1—kidney cancer	2.94e-05	0.000213	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MYC—kidney cancer	2.93e-05	0.000212	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PSMD7—kidney cancer	2.92e-05	0.000212	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—kidney cancer	2.9e-05	0.000211	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK1—kidney cancer	2.86e-05	0.000208	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.85e-05	0.000207	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	2.8e-05	0.000203	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—BCHE—kidney cancer	2.76e-05	0.000201	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.73e-05	0.000198	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KRAS—kidney cancer	2.7e-05	0.000196	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CA9—kidney cancer	2.65e-05	0.000192	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.64e-05	0.000191	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.56e-05	0.000186	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.49e-05	0.00018	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CA—kidney cancer	2.48e-05	0.00018	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—kidney cancer	2.47e-05	0.000179	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTP1—kidney cancer	2.45e-05	0.000178	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—kidney cancer	2.4e-05	0.000175	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK3—kidney cancer	2.33e-05	0.000169	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ABCB1—kidney cancer	2.32e-05	0.000168	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTM1—kidney cancer	2.25e-05	0.000163	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CRABP1—kidney cancer	2.25e-05	0.000163	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.23e-05	0.000162	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK1—kidney cancer	2.22e-05	0.000161	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTP1—kidney cancer	2.2e-05	0.00016	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1A1—kidney cancer	2.13e-05	0.000155	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KRAS—kidney cancer	2.1e-05	0.000152	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ITPR2—kidney cancer	2.09e-05	0.000152	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ABCB1—kidney cancer	2.08e-05	0.000151	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTM1—kidney cancer	2.02e-05	0.000147	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CA—kidney cancer	1.93e-05	0.00014	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.92e-05	0.000139	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ACHE—kidney cancer	1.91e-05	0.000139	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTT1—kidney cancer	1.91e-05	0.000139	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—kidney cancer	1.86e-05	0.000135	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SCARB1—kidney cancer	1.81e-05	0.000131	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS1—kidney cancer	1.79e-05	0.00013	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.75e-05	0.000127	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PSMD7—kidney cancer	1.75e-05	0.000127	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—BCHE—kidney cancer	1.66e-05	0.000121	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000119	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—POMC—kidney cancer	1.59e-05	0.000116	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.59e-05	0.000115	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.57e-05	0.000114	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—POMC—kidney cancer	1.43e-05	0.000104	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTP1—kidney cancer	1.32e-05	9.6e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—kidney cancer	1.27e-05	9.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ABCB1—kidney cancer	1.25e-05	9.09e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTM1—kidney cancer	1.22e-05	8.82e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.15e-05	8.37e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—kidney cancer	1.14e-05	8.27e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTEN—kidney cancer	1.11e-05	8.04e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTEN—kidney cancer	9.94e-06	7.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—POMC—kidney cancer	8.59e-06	6.24e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CA—kidney cancer	7.81e-06	5.67e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.01e-06	5.09e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—kidney cancer	6.85e-06	4.98e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTEN—kidney cancer	5.97e-06	4.34e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.22e-06	3.06e-05	CbGpPWpGaD
